Amicus Therapeutics, Inc. (LON:0HF9)
6.57
-0.20 (-3.01%)
At close: May 2, 2025
Amicus Therapeutics Employees
Amicus Therapeutics had 499 employees as of December 31, 2024. The number of employees decreased by 18 or -3.48% compared to the previous year.
Employees
499
Change (1Y)
-18
Growth (1Y)
-3.48%
Revenue / Employee
842.46K GBP
Profits / Employee
-45.56K GBP
Market Cap
1.54B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Genus | 3,500 |
Amicus Therapeutics News
- 2 days ago - Amicus Therapeutics, Inc. (FOLD) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - Amicus Therapeutics Non-GAAP EPS of $0.03 misses by $0.05, revenue of $125.2M misses by $11.15M - Seeking Alpha
- 2 days ago - Amicus Therapeutics Announces First Quarter 2025 Financial Results and Corporate Updates - GlobeNewsWire
- 2 days ago - Earnings Scheduled For May 1, 2025 - Benzinga
- 3 days ago - Dimerix and Amicus Therapeutics Announce Exclusive License Agreement for DMX-200 in the United States - GlobeNewsWire
- 3 days ago - Amicus Therapeutics Q1 2025 Earnings Preview - Seeking Alpha
- 3 days ago - Amicus Therapeutics Earnings Preview - Benzinga
- 12 days ago - Amicus Therapeutics to Announce First Quarter 2025 Financial Results on May 1, 2025 - GlobeNewsWire